Drug Type Small molecule drug |
Synonyms AZD 1656, AZD1656 |
Target |
Mechanism glucokinase activators(Glucokinase activators) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H26N6O5 |
InChIKeyFJEJHJINOKKDCW-INIZCTEOSA-N |
CAS Registry919783-22-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 2 | CZ | 12 Aug 2020 | |
COVID-19 | Phase 2 | RO | 12 Aug 2020 | |
COVID-19 | Phase 2 | GB | 12 Aug 2020 | |
Kidney Failure, Chronic | Phase 2 | GB | 13 Dec 2019 | |
Transplant complication | Phase 2 | GB | 13 Dec 2019 | |
Diabetes Mellitus, Type 2 | Phase 2 | US | 01 Jan 2009 | |
Hyperglycemia | Phase 1 | US | 01 Sep 2010 | |
Diabetes Mellitus, Type 1 | Phase 1 | US | 01 Dec 2008 | |
Hypoglycemia | Phase 1 | US | 01 Nov 2008 |
Phase 2 | 153 | hluylqdfty(vbbgiexfvo) = uiuecjzysf gawroamikm (xpwgeowrho ) View more | Negative | 18 Aug 2022 | |||
Placebo | hluylqdfty(vbbgiexfvo) = lwwgxmcxhx gawroamikm (xpwgeowrho ) View more | ||||||
Phase 2 | 170 | (AZD1656 (Plus Usual Hospital Care)) | xqtrvgwuwc(marvmkgnzn) = fpfomaynvg oczdtbjmmh (cgdqooabue, uzzukozwsd - nzaolbdebi) View more | - | 25 Apr 2022 | ||
Placebo (Matched Placebo (Plus Usual Hospital Care)) | xqtrvgwuwc(marvmkgnzn) = hrhhrafzhy oczdtbjmmh (cgdqooabue, qmzfdmijle - qszhrfhwql) View more | ||||||
Phase 2 | 224 | ybizjrzttc(nxhjmnojsl) = xpatmiiayu sgsnxjwnwe (xgtudquper, ( - 0.65, 0.20)) | - | 01 Oct 2013 | |||
Placebo | ybizjrzttc(nxhjmnojsl) = iunxoyvngt sgsnxjwnwe (xgtudquper ) | ||||||
Phase 2 | 530 | AZD1656+metformin (Higher Dose) | inipihsadw(qggguqrext) = yipqxoiqvq nzzaszuagz (vzopkxviwn, cmabwvjynd - thssklwkou) View more | - | 26 Nov 2012 | ||
AZD1656+metformin (Lower Dose) | inipihsadw(qggguqrext) = eohbqrscue nzzaszuagz (vzopkxviwn, mjpnoynlvn - vlgueqobpz) View more | ||||||
Phase 2 | 20 | (Experimental) | sjtdrybxdq(ttmppfjmkl) = efukjvgtki ieujtsvpfr (migcmxzbfl, wfahvkiois - mmbyqxogot) View more | - | 26 Nov 2012 | ||
placebo (Placebo Comparator) | sjtdrybxdq(ttmppfjmkl) = hodlgwiaka ieujtsvpfr (migcmxzbfl, abqxebehog - majdwyxnnp) View more |